Asymmetric Fc Engineering for Bispecific Antibodies with Reduced Effector Function
Asymmetric bispecific antibodies are a rapidly expanding therapeutic antibody class, designed to recognize two different target epitopes concurrently to achieve novel functions not available with normal antibodies. Many therapeutic designs require antibodies with reduced or silenced effector functio...
Main Authors: | Eric Escobar-Cabrera, Paula Lario, Jason Baardsnes, Joseph Schrag, Yves Durocher, Surjit Dixit |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-05-01
|
Series: | Antibodies |
Subjects: | |
Online Access: | http://www.mdpi.com/2073-4468/6/2/7 |
Similar Items
-
Engineering of aglycosylated antibody Fc for effector functions
by: Jung, Sang Taek
Published: (2014) -
Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease
by: Elisabeth A. van Erp, et al.
Published: (2019-03-01) -
Immunoglobulin Fc heterodimer platform technology: From design to applications in therapeutic antibodies and proteins
by: Ji-Hee Ha, et al.
Published: (2016-10-01) -
Natural Killer (NK)- and T-Cell Engaging Antibody-Derived Therapeutics
by: Christoph Stein, et al.
Published: (2012-06-01) -
Requirement of Fc-Fc Gamma Receptor Interaction for Antibody-Based Protection against Emerging Virus Infections
by: Shamus P. Keeler, et al.
Published: (2021-05-01)